Neuronetics (STIM) Capital Expenditures Growth (1y) (2018 - 2026)
Neuronetics (STIM) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -47.73% |
| 10 | Neuronetics | 120.39 Mn | 114.38 Mn | 16.15 Mn | 358.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 358.14% |
| Dec 31, 2025 | 500.00% |
| Sep 30, 2025 | 559.52% |
| Jun 30, 2025 | -117.65% |
| Mar 31, 2025 | -79.52% |
| Dec 31, 2024 | 43.75% |
| Sep 30, 2024 | 79.10% |
| Jun 30, 2024 | -102.41% |
| Mar 31, 2024 | -10.26% |
| Dec 31, 2023 | -119.09% |
| Sep 30, 2023 | -183.06% |
| Jun 30, 2023 | -27.12% |
| Mar 31, 2023 | -78.21% |
| Dec 31, 2022 | -74.27% |
| Sep 30, 2022 | 202.25% |
| Jun 30, 2022 | 4.77% |
| Mar 31, 2022 | 477.42% |
| Dec 31, 2021 | 580.34% |
| Sep 30, 2021 | -232.71% |
| Jun 30, 2021 | 6,685.71% |